Gabriele Matschiner

Gabriele Matschiner

Company: Pieris Pharmaceuticals

Job title: Director Respiratory


Anticalin Platform for Development of Inhaled Therapies in Chronic Airway Disease 2:00 pm

Bullet points: inhaled Anticalin antagonists for respiratory disease Benefits of local intervention via inhalation versus systemic administration Development of PRS-060, a potential first-in-class, inhaled IL-4Ra inhibitor for the treatment of asthmaRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.